[S02DA03, antipyrine, The risk or severity of bleeding can be increased when Zidovudine is combined with Antipyrine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Zidovudine.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Zidovudine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Zidovudine.]
[L04AA27, fingolimod, Zidovudine may increase the immunosuppressive activities of Fingolimod.]
[J01EC02, sulfadiazine, The metabolism of Zidovudine can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Zidovudine can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Zidovudine.]
[J01EC03, sulfamoxole, The metabolism of Zidovudine can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Zidovudine can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Zidovudine can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Zidovudine can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, The risk or severity of bleeding can be increased when Zidovudine is combined with Sulindac.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Zidovudine.]
[M01AX04, apazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Azapropazone.]
[L01BB02, mercaptopurine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mercaptopurine.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Zidovudine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Zidovudine.]
[L01CB02, teniposide, The risk or severity of adverse effects can be increased when Teniposide is combined with Zidovudine.]
[B01AE07, dabigatran etexilate, The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Zidovudine.]
[G03BA03, testosterone, The excretion of Zidovudine can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Zidovudine.]
[A04AD10, dronabinol, The metabolism of Zidovudine can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Zidovudine.]
[L04AX02, thalidomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Thalidomide.]
[R03DA04, theophylline, The metabolism of Zidovudine can be decreased when combined with Theophylline.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Eribulin.]
[L01AC01, thiotepa, The risk or severity of adverse effects can be increased when Zidovudine is combined with Thiotepa.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Zidovudine.]
[B01AC05, ticlopidine, The risk or severity of bleeding can be increased when Ticlopidine is combined with Zidovudine.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Zidovudine.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Zidovudine.]
[M02AA21, tolmetin, The risk or severity of bleeding can be increased when Zidovudine is combined with Tolmetin.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Zidovudine.]
[N06AF04, tranylcypromine, The metabolism of Zidovudine can be decreased when combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Zidovudine.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Tretinoin.]
[S01BA05, triamcinolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Triamcinolone.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Zidovudine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Zidovudine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluclorolone.]
[R03BA07, mometasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Zidovudine can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Zidovudine can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Zidovudine.]
[J01FA08, troleandomycin, The metabolism of Zidovudine can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, Roflumilast may increase the immunosuppressive activities of Zidovudine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belimumab.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Zidovudine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Zidovudine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Zidovudine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Zidovudine can be decreased when combined with Telaprevir.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Zidovudine.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belatacept.]
[N03AX21, ezogabine, The metabolism of Ezogabine can be increased when combined with Zidovudine.]
[B01AF01, rivaroxaban, The risk or severity of bleeding can be increased when Rivaroxaban is combined with Zidovudine.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be increased when combined with Zidovudine.]
[B01AC24, ticagrelor, The risk or severity of bleeding can be increased when Ticagrelor is combined with Zidovudine.]
[C08DA01, verapamil, The metabolism of Zidovudine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Zidovudine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vinblastine.]
[L01CA02, vincristine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vincristine.]
[L01CA03, vindesine, The risk or severity of adverse effects can be increased when Vindesine is combined with Zidovudine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Zidovudine.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Warfarin is combined with Zidovudine.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be increased when combined with Zidovudine.]
[J05AE02, indinavir, The metabolism of Zidovudine can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Zidovudine.]
[L01FX05, brentuximab vedotin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Zidovudine can be decreased when combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.]
[R03DC01, zafirlukast, The metabolism of Zidovudine can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Zidovudine can be decreased when combined with Ziprasidone.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Zidovudine.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Zidovudine is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ruxolitinib.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Zidovudine.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Zidovudine.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Zidovudine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Zidovudine.]
[J02AC03, voriconazole, The metabolism of Zidovudine can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Zidovudine.]
[H02AB11, prednylidene, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednylidene.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Zidovudine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Zidovudine.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Zidovudine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Zidovudine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Zidovudine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Zidovudine.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Zidovudine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Zidovudine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Zidovudine can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Bosutinib.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Teriflunomide.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Zidovudine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Aldosterone.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Zidovudine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Bendamustine.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Lercanidipine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Zidovudine.]
[L04AA29, tofacitinib, Zidovudine may increase the immunosuppressive activities of Tofacitinib.]
[L01EX07, cabozantinib, The metabolism of Zidovudine can be decreased when combined with Cabozantinib.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Zidovudine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Zidovudine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Zidovudine.]
[C03AA01, bendroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Zidovudine.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Zidovudine.]
[N02BA10, benorilate, The risk or severity of bleeding can be increased when Zidovudine is combined with Benorilate.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dimethyl fumarate.]
[M04AB03, benzbromarone, The metabolism of Zidovudine can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Zidovudine can be decreased when combined with Tegaserod.]
[J02AX04, caspofungin, The excretion of Zidovudine can be decreased when combined with Caspofungin.]
[M01AH01, celecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Celecoxib.]
[L04AA18, everolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Everolimus.]
[L03AB03, gamma-interferon, The risk or severity of adverse effects can be increased when Interferon Gamma is combined with Zidovudine.]
[L01EC02, dabrafenib, The serum concentration of Zidovudine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of bleeding can be increased when Zidovudine is combined with Benzydamine.]
[L01EE01, trametinib, The metabolism of Zidovudine can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Zidovudine.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Zidovudine.]
[J05AJ03, dolutegravir, The excretion of Zidovudine can be decreased when combined with Dolutegravir.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Zidovudine.]
[L03AA14, lipegfilgrastim, Zidovudine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Zidovudine.]
[G03XC02, bazedoxifene, The metabolism of Bazedoxifene can be increased when combined with Zidovudine.]
[L01EL01, ibrutinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Zidovudine.]
[N03AF04, eslicarbazepine, The metabolism of Eslicarbazepine can be increased when combined with Zidovudine.]
[J05AP05, simeprevir, The metabolism of Zidovudine can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Zidovudine.]
[A16AA07, metreleptin, The metabolism of Zidovudine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Zidovudine can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The risk or severity of adverse effects can be increased when Betamethasone is combined with Zidovudine.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Zidovudine.]
[V03AB34, fomepizole, The metabolism of Zidovudine can be decreased when combined with Fomepizole.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Zidovudine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Zidovudine can be decreased when combined with Ceritinib.]
[B01AC26, vorapaxar, The risk or severity of bleeding can be increased when Vorapaxar is combined with Zidovudine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vedolizumab.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Acenocoumarol is combined with Zidovudine.]
[L01XH04, belinostat, The metabolism of Belinostat can be increased when combined with Zidovudine.]
[L01EM01, idelalisib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Idelalisib.]
[N07XX08, tafamidis, The serum concentration of Zidovudine can be increased when it is combined with Tafamidis.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Zidovudine.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Zidovudine is combined with Peginterferon beta-1a.]
[J01XA05, oritavancin, The metabolism of Zidovudine can be decreased when combined with Oritavancin.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Decitabine.]
[L04AX05, pirfenidone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pirfenidone.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Zidovudine.]
[S03AA06, gentamicin, The excretion of Zidovudine can be decreased when combined with Gentamicin.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Blinatumomab.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01XK01, olaparib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Olaparib.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Zidovudine.]
[B01AF03, edoxaban, The risk or severity of bleeding can be increased when Edoxaban is combined with Zidovudine.]
[L04AC10, secukinumab, The metabolism of Zidovudine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Palbociclib.]
[L01EX08, lenvatinib, The excretion of Zidovudine can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The risk or severity of adverse effects can be increased when Zidovudine is combined with Panobinostat.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N02BE01, acetaminophen, The metabolism of Zidovudine can be decreased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Zidovudine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Zidovudine.]
[J05AF08, adefovir dipivoxil, The excretion of Zidovudine can be decreased when combined with Adefovir dipivoxil.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Zidovudine.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Zidovudine.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Zidovudine.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M02AA25, aceclofenac, The risk or severity of bleeding can be increased when Zidovudine is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Acemetacin.]
[S01EC01, acetazolamide, The excretion of Zidovudine can be decreased when combined with Acetazolamide.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Acipimox.]
[A02BC03, lansoprazole, The excretion of Zidovudine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trabectedin.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Zidovudine can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The excretion of Tenofovir alafenamide can be decreased when combined with Zidovudine.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Zidovudine.]
[A10BB31, acetohexamide, The metabolism of Zidovudine can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Zidovudine.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Alminoprofen.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Zidovudine.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Zidovudine can be decreased when combined with Venetoclax.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Zidovudine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be increased when combined with Zidovudine.]
[L01AB01, busulfan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Busulfan.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Zidovudine.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Zidovudine.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Zidovudine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of bleeding can be increased when Zidovudine is combined with Balsalazide.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Zidovudine.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Zidovudine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Zidovudine is combined with Linezolid.]
[J05AE09, tipranavir, The metabolism of Zidovudine can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Zidovudine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Zidovudine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Zidovudine.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AC14, sarilumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Delafloxacin can be increased when combined with Zidovudine.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Zidovudine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Guselkumab.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Zidovudine.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Zidovudine is combined with Vorinostat.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Zidovudine can be decreased when combined with Efavirenz.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Zidovudine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Zidovudine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.]
[R03BA02, budesonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Zidovudine.]
[M01AB07, bumadizone, The risk or severity of bleeding can be increased when Zidovudine is combined with Bumadizone.]
[J05AX18, letermovir, The excretion of Zidovudine can be decreased when combined with Letermovir.]
[A10BK04, ertugliflozin, The metabolism of Zidovudine can be decreased when combined with Ertugliflozin.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Zidovudine.]
[L02BB05, apalutamide, The metabolism of Zidovudine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carbamazepine.]
[J01CA03, carbenicillin, The excretion of Zidovudine can be decreased when combined with Carbenicillin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Zidovudine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Zidovudine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Zidovudine.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B02BX08, avatrombopag, The excretion of Zidovudine can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Zidovudine.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be increased when combined with Zidovudine.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Zidovudine.]
[H01CC03, elagolix, The metabolism of Elagolix can be increased when combined with Zidovudine.]
[L01XX62, ivosidenib, The metabolism of Zidovudine can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, The metabolism of Migalastat can be increased when combined with Zidovudine.]
[N03AX17, stiripentol, The metabolism of Zidovudine can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Zidovudine can be increased when combined with Tecovirimat.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Zidovudine.]
[M01AC05, lornoxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Lornoxicam.]
[L04AA39, emapalumab, The metabolism of Zidovudine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Zidovudine.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ravulizumab.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Zidovudine.]
[B01AC23, cilostazol, The risk or severity of bleeding can be increased when Cilostazol is combined with Zidovudine.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Zidovudine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Zidovudine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Siponimod.]
[J01FA09, clarithromycin, Clarithromycin may increase the myelosuppressive activities of Zidovudine.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Zidovudine.]
[H02AB14, cloprednol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ubidecarenone.]
[C09CA06, candesartan, The metabolism of Zidovudine can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Zidovudine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Zidovudine can be decreased when it is combined with Alpelisib.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Zidovudine.]
[J01DB05, cefadroxil, The excretion of Zidovudine can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Zidovudine can be decreased when combined with Cefamandole.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Zidovudine.]
[L02BB06, darolutamide, The serum concentration of Zidovudine can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Zidovudine can be decreased when combined with Pexidartinib.]
[J01DD12, cefoperazone, The excretion of Zidovudine can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Zidovudine can be decreased when combined with Cefotaxime.]
[J01DC07, cefotiam, The excretion of Zidovudine can be decreased when combined with Cefotiam.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Zidovudine.]
[J01DD04, ceftriaxone, The excretion of Zidovudine can be decreased when combined with Ceftriaxone.]
[L04AA44, upadacitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Upadacitinib.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N07XX11, pitolisant, The serum concentration of Zidovudine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C03AA09, cyclothiazide, The excretion of Zidovudine can be decreased when combined with Cyclothiazide.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Zidovudine.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Zidovudine.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Zidovudine.]
[J01DB03, cephalothin, The excretion of Zidovudine can be decreased when combined with Cefalotin.]
[J01DB09, cephradine, The excretion of Zidovudine can be decreased when combined with Cefradine.]
[H02AB13, deflazacort, The risk or severity of adverse effects can be increased when Zidovudine is combined with Deflazacort.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Zidovudine.]
[L01FD03, ado-trastuzumab emtansine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trastuzumab emtansine.]
[N02CC08, lasmiditan, The serum concentration of Zidovudine can be increased when it is combined with Lasmiditan.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Diroximel fumarate.]
[G03AC09, desogestrel, The metabolism of Zidovudine can be increased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Zidovudine.]
[N03AX25, cenobamate, The serum concentration of Zidovudine can be decreased when it is combined with Cenobamate.]
[L01EX18, avapritinib, The metabolism of Zidovudine can be decreased when combined with Avapritinib.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Teprotumumab.]
[N05AD10, lumateperone, The metabolism of Lumateperone can be increased when combined with Zidovudine.]
[M01AX21, diacetylrhein, The metabolism of Zidovudine can be decreased when combined with Diacerein.]
[J05AE05, amprenavir, The metabolism of Zidovudine can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ozanimod.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be increased when combined with Zidovudine.]
[N02CC06, eletriptan, The metabolism of Zidovudine can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Rofecoxib.]
[L01XF03, bexarotene, The risk or severity of adverse effects can be increased when Bexarotene is combined with Zidovudine.]
[C08CA16, clevidipine, The metabolism of Zidovudine can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The excretion of Zidovudine can be decreased when combined with Dronedarone.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Zidovudine.]
[S03AA08, chloramphenicol, The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Zidovudine.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Zidovudine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Zidovudine.]
[L01EX17, capmatinib, The serum concentration of Zidovudine can be increased when it is combined with Capmatinib.]
[D07XB03, fluprednidene, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Droxicam.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Zidovudine can be increased when it is combined with Selpercatinib.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Zidovudine.]
[M02AA27, dexketoprofen, The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Zidovudine.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Zidovudine.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Zidovudine is combined with Inebilizumab.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Stepronin.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Zidovudine.]
[L04AC19, satralizumab, The serum concentration of Zidovudine can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Chloroquine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C03AA04, chlorothiazide, The excretion of Zidovudine can be decreased when combined with Chlorothiazide.]
[A10BB02, chlorpropamide, The excretion of Zidovudine can be decreased when combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Zidovudine can be decreased when combined with Chlorzoxazone.]
[N02BA07, ethenzamide, The risk or severity of bleeding can be increased when Zidovudine is combined with Ethenzamide.]
[M01AB08, etodolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of bleeding can be increased when Zidovudine is combined with Etofenamate.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Zidovudine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Zidovudine can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fludarabine.]
[J05AJ04, cabotegravir, The excretion of Zidovudine can be decreased when combined with Cabotegravir.]
[L04AD03, voclosporin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Zidovudine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Zidovudine can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Zidovudine can be decreased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of bleeding can be increased when Zidovudine is combined with Fenbufen.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Zidovudine.]
[R03BA03, flunisolide, The risk or severity of adverse effects can be increased when Flunisolide is combined with Zidovudine.]
[S02BA08, fluocinolone acetonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Zidovudine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Zidovudine.]
[L04AA50, ponesimod, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ponesimod.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Zidovudine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Zidovudine.]
[J01MB06, cinoxacin, The excretion of Zidovudine can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Zidovudine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Zidovudine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cisplatin.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pegcetacoplan.]
[C03DA05, finerenone, The metabolism of Finerenone can be decreased when combined with Zidovudine.]
[L04AA48, belumosudil, The risk or severity of adverse effects can be increased when Zidovudine is combined with Belumosudil.]
[P01CA03, fexinidazole, The excretion of Zidovudine can be decreased when combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Anifrolumab.]
[M01AG01, mefenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Zidovudine can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Zidovudine.]
[N06AX25, St. John's wort extract, The metabolism of Zidovudine can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Zidovudine can be decreased when combined with Asciminib.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Zidovudine.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Zidovudine.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Zidovudine can be increased when combined with Mitapivat.]
[L01EJ03, pacritinib, The serum concentration of Zidovudine can be increased when it is combined with Pacritinib.]
[C01EB24, mavacamten, The serum concentration of Zidovudine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Zidovudine.]
[J02AC06, oteseconazole, The serum concentration of Zidovudine can be increased when it is combined with Oteseconazole.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Deucravacitinib.]
[H01CC04, linzagolix, The serum concentration of Zidovudine can be increased when it is combined with Linzagolix.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Zidovudine.]
[J05AX31, lenacapavir, The metabolism of Lenacapavir can be increased when combined with Zidovudine.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Zidovudine is combined with Clozapine.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Zidovudine can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Zidovudine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Proquazone.]
[R05DA04, codeine, The excretion of Zidovudine can be decreased when combined with Codeine.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Colchicine.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Leflunomide.]
[A10BX03, nateglinide, The excretion of Zidovudine can be decreased when combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of bleeding can be increased when Zidovudine is combined with Imidazole salicylate.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Zidovudine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ciclesonide.]
[B01AC10, indobufen, The risk or severity of bleeding can be increased when Zidovudine is combined with Indobufen.]
[J05AB14, valganciclovir, The risk or severity of cytopenia can be increased when Valganciclovir is combined with Zidovudine.]
[M01AH03, valdecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Zidovudine.]
[M01AH04, parecoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Zidovudine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Zidovudine.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Acyclovir is combined with Zidovudine.]
[M01AA06, kebuzone, The risk or severity of bleeding can be increased when Zidovudine is combined with Kebuzone.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be increased when combined with Zidovudine.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Zidovudine can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Zidovudine can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, The metabolism of Lamotrigine can be increased when combined with Zidovudine.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Nafarelin.]
[M01AB09, lonazolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Lonazolac.]
[R06AX13, loratadine, The metabolism of Zidovudine can be decreased when combined with Loratadine.]
[M02AA31, loxoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Loxoprofen.]
[C08CA11, manidipine, The metabolism of Zidovudine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Mebeverine.]
[H02AB15, meprednisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Meprednisone.]
[R06AE03, cyclizine, The metabolism of Zidovudine can be decreased when combined with Cyclizine.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Zidovudine.]
[C03AA07, cyclopenthiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Zidovudine.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Zidovudine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Zidovudine.]
[S01XA18, cyclosporine, Zidovudine may increase the immunosuppressive activities of Cyclosporine.]
[N06BA07, modafinil, The metabolism of Zidovudine can be decreased when combined with Armodafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Zidovudine.]
[M02AA02, mofebutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of bleeding can be increased when Zidovudine is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Zidovudine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Cytarabine.]
[M01AH05, etoricoxib, The risk or severity of bleeding can be increased when Zidovudine is combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dactinomycin.]
[G03XA01, danazol, The metabolism of Zidovudine can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Zidovudine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Zidovudine can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The risk or severity of bleeding can be increased when Zidovudine is combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Zidovudine can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Zidovudine can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be increased when combined with Zidovudine.]
[B01AX05, fondaparinux, The risk or severity of bleeding can be increased when Fondaparinux is combined with Zidovudine.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zidovudine.]
[A07EC03, olsalazine, The risk or severity of bleeding can be increased when Zidovudine is combined with Olsalazine.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Desoximetasone.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Oxaliplatin.]
[M01AE12, oxaprozin, The risk or severity of bleeding can be increased when Zidovudine is combined with Oxaprozin.]
[S03BA01, dexamethasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Zidovudine can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Zidovudine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N06BA02, dextroamphetamine, The metabolism of Zidovudine can be decreased when combined with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Zidovudine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Zidovudine.]
[N06AB05, paroxetine, The metabolism of Zidovudine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Zidovudine can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Zidovudine.]
[S01BC03, diclofenac, The risk or severity of bleeding can be increased when Zidovudine is combined with Diclofenac.]
[J05AD01, foscarnet, The excretion of Zidovudine can be decreased when combined with Foscarnet.]
[A10BG03, pioglitazone, The metabolism of Zidovudine can be decreased when combined with Pioglitazone.]
[L01DC04, ixabepilone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Zidovudine.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pirarubicin.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Zidovudine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of bleeding can be increased when Zidovudine is combined with Diflunisal.]
[C10AX09, ezetimibe, The metabolism of Ezetimibe can be increased when combined with Zidovudine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Zidovudine.]
[N02AA03, hydromorphone, The metabolism of Zidovudine can be decreased when combined with Hydromorphone.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Zidovudine.]
[J05AE08, atazanavir, The metabolism of Zidovudine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Zidovudine can be decreased when combined with Treprostinil.]
[C08DB01, diltiazem, The metabolism of Zidovudine can be decreased when combined with Diltiazem.]
[N02BB04, propyphenazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Zidovudine.]
[C05CA03, diosmin, The metabolism of Zidovudine can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Zidovudine.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Zidovudine.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Zidovudine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Zidovudine.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Zidovudine.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Zidovudine.]
[S01XA23, sirolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sirolimus.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Natalizumab.]
[S02AA12, rifamycin SV, The metabolism of Zidovudine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Zidovudine can be increased when combined with Rifapentine.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Zidovudine.]
[L01EX01, sunitinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Zidovudine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The risk or severity of adverse effects can be increased when Bortezomib is combined with Zidovudine.]
[S01BC05, ketorolac, The risk or severity of bleeding can be increased when Zidovudine is combined with Ketorolac.]
[N02BA06, salsalate, The risk or severity of bleeding can be increased when Zidovudine is combined with Salsalate.]
[R03AC12, salmeterol, The metabolism of Zidovudine can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Zidovudine.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Zidovudine.]
[L01DB01, doxorubicin, The risk or severity of adverse effects can be increased when Doxorubicin is combined with Zidovudine.]
[N06AB06, sertraline, The metabolism of Zidovudine can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Zidovudine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be increased when combined with Zidovudine.]
[H01AA01, corticotropin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Zidovudine.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Temozolomide.]
[M01AC02, tenoxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Tenoxicam.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Tianeptine.]
[C09AA02, enalapril, The excretion of Zidovudine can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Tolfenamic acid.]
[C03CA04, torsemide, The metabolism of Zidovudine can be decreased when combined with Torasemide.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Zidovudine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trilostane.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Trofosfamide.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Zidovudine.]
[L01CA04, vinorelbine, The risk or severity of adverse effects can be increased when Vinorelbine is combined with Zidovudine.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Zidovudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA12, mepirodipine, The metabolism of Zidovudine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Zidovudine can be decreased when combined with Epinephrine.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Zidovudine.]
[N05CF02, zolpidem, The metabolism of Zidovudine can be decreased when combined with Zolpidem.]
[M01AB04, zomepirac, The risk or severity of bleeding can be increased when Zidovudine is combined with Zomepirac.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be increased when combined with Zidovudine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Zidovudine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carboplatin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Zidovudine can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Zidovudine can be decreased when combined with Erythromycin.]
[A02BC02, pantoprazole, The excretion of Zidovudine can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Zidovudine.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Estramustine.]
[G03CA57, estrogens, conjugated (USP), The excretion of Zidovudine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Zidovudine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be increased when combined with Zidovudine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Zidovudine.]
[M01AC06, meloxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Meloxicam.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Zidovudine.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Zidovudine.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Nizatidine.]
[R06AX12, terfenadine, The metabolism of Zidovudine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Zidovudine.]
[N06AB08, fluvoxamine, The metabolism of Zidovudine can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Zidovudine.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Zidovudine.]
[C10AA03, pravastatin, The excretion of Zidovudine can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, The metabolism of Zidovudine can be decreased when combined with Sodium aurothiomalate.]
[A05AA01, chenodeoxycholic acid, The metabolism of Zidovudine can be decreased when combined with Chenodeoxycholic acid.]
[B05AA05, dextran, The risk or severity of bleeding can be increased when Dextran is combined with Zidovudine.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Zidovudine.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Zidovudine.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Zidovudine.]
[C08CA02, felodipine, The metabolism of Zidovudine can be decreased when combined with Felodipine.]
[M01AE04, fenoprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Fenoprofen.]
[L03AB02, interferon-beta, The risk or severity of adverse effects can be increased when Human interferon beta is combined with Zidovudine.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Zidovudine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Zidovudine.]
[C01BC04, flecainide, The metabolism of Zidovudine can be decreased when combined with Flecainide.]
[N02BG04, floctafenine, The risk or severity of bleeding can be increased when Zidovudine is combined with Floctafenine.]
[J02AC01, fluconazole, The metabolism of Zidovudine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fludrocortisone.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Zidovudine.]
[N05CD03, flunitrazepam, The metabolism of Zidovudine can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocinonide.]
[H02AB03, fluocortolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Zidovudine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Zidovudine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Zidovudine.]
[N06AB03, fluoxetine, The metabolism of Zidovudine can be decreased when combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Zidovudine.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Zidovudine.]
[S01BC04, flurbiprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Flurbiprofen.]
[V04CX02, folic acid, The excretion of Zidovudine can be decreased when combined with Folic acid.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Zidovudine.]
[J05AE10, darunavir, The metabolism of Zidovudine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The excretion of Zidovudine can be decreased when combined with Furosemide.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Alendronic acid.]
[N05CF04, eszopiclone, The metabolism of Zidovudine can be decreased when combined with Eszopiclone.]
[S01AD09, ganciclovir, The excretion of Zidovudine can be decreased when combined with Ganciclovir.]
[C10AB04, gemfibrozil, The metabolism of Zidovudine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The risk or severity of adverse effects can be increased when Zidovudine is combined with Dasatinib.]
[J05AG04, etravirine, The metabolism of Zidovudine can be decreased when combined with Etravirine.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Zidovudine.]
[A10BB01, glyburide, The metabolism of Zidovudine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Zidovudine.]
[A10BB07, glipizide, The metabolism of Glipizide can be increased when combined with Zidovudine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Zidovudine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Zidovudine.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Zidovudine.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Zidovudine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Zidovudine.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Zidovudine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Zidovudine.]
[M04AA01, allopurinol, The risk or severity of adverse effects can be increased when Allopurinol is combined with Zidovudine.]
[C09CA01, losartan, The metabolism of Losartan can be increased when combined with Zidovudine.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Zidovudine.]
[A07EC02, mesalamine, The risk or severity of bleeding can be increased when Zidovudine is combined with Mesalazine.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Zidovudine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Zidovudine.]
[C08CA10, nilvadipine, The metabolism of Zidovudine can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of bleeding can be increased when Zidovudine is combined with Nimesulide.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Zidovudine.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Zidovudine.]
[C03AA02, hydroflumethiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Zidovudine.]
[P01BA02, hydroxychloroquine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydroxychloroquine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydroxyurea.]
[J04AB04, rifabutin, The metabolism of Zidovudine can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of bleeding can be increased when Zidovudine is combined with Ibuprofen.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Zidovudine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Idarubicin.]
[L01AA06, ifosfamide, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ifosfamide.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Zidovudine.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Zidovudine is combined with Tixocortol.]
[L01CE01, topotecan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Topotecan.]
[S01BC01, indomethacin, The risk or severity of bleeding can be increased when Zidovudine is combined with Indomethacin.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Zidovudine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Zidovudine.]
[N06AX17, milnacipran, The metabolism of Zidovudine can be decreased when combined with Milnacipran.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Eculizumab.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Zidovudine.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Zidovudine.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be increased when combined with Zidovudine.]
[L01XX35, anagrelide, The risk or severity of bleeding can be increased when Anagrelide is combined with Zidovudine.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Zidovudine.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ipecac.]
[J05AF04, stavudine, The therapeutic efficacy of Stavudine can be decreased when used in combination with Zidovudine.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Zidovudine.]
[N06AF05, iproniazid, The metabolism of Zidovudine can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Zidovudine can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Zidovudine can be decreased when combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ivermectin.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Zidovudine.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.]
[L04AC07, tocilizumab, The metabolism of Zidovudine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Zidovudine.]
[C02KD01, ketanserin, The risk or severity of bleeding can be increased when Ketanserin is combined with Zidovudine.]
[B01AC22, prasugrel, The risk or severity of bleeding can be increased when Prasugrel is combined with Zidovudine.]
[J02AB02, ketoconazole, The metabolism of Zidovudine can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Zidovudine can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Zidovudine can be decreased when combined with Olanzapine.]
[M02AA10, ketoprofen, The risk or severity of adverse effects can be increased when Ketoprofen is combined with Zidovudine.]
[V03AC03, deferasirox, The metabolism of Deferasirox can be increased when combined with Zidovudine.]
[L04AA24, abatacept, The metabolism of Zidovudine can be increased when combined with Abatacept.]
[J01MB02, nalidixic acid, The excretion of Zidovudine can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Tiaprofenic acid.]
[C07AG01, labetalol, The metabolism of Labetalol can be increased when combined with Zidovudine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Zidovudine.]
[C03CC01, ethacrynic acid, The excretion of Zidovudine can be decreased when combined with Etacrynic acid.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Zidovudine.]
[N06BA13, armodafinil, The metabolism of Zidovudine can be decreased when combined with Armodafinil.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Zidovudine.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be increased when combined with Zidovudine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Zidovudine.]
[L01EG01, temsirolimus, The risk or severity of adverse effects can be increased when Zidovudine is combined with Temsirolimus.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Zidovudine can be decreased when combined with Nilotinib.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mechlorethamine.]
[M02AA18, meclofenamic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Meclofenamic acid.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Zidovudine.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Zidovudine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Zidovudine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Zidovudine.]
[N05CH01, melatonin, The excretion of Zidovudine can be decreased when combined with Melatonin.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Zidovudine is combined with Melphalan.]
[N06DX01, memantine, The metabolism of Zidovudine can be decreased when combined with Memantine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Zidovudine.]
[N07BC02, methadone, The serum concentration of Zidovudine can be increased when it is combined with Methadone.]
[S01EC05, methazolamide, The excretion of Zidovudine can be decreased when combined with Methazolamide.]
[H03BB02, methimazole, The metabolism of Zidovudine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Zidovudine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Methotrexate.]
[D05BA02, methoxsalen, The metabolism of Zidovudine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Zidovudine.]
[C03AA08, methyclothiazide, The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Zidovudine.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Zidovudine can be decreased when combined with Methylene blue.]
[H02AB04, methylprednisolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Methylprednisolone.]
[G03EK01, methyltestosterone, The excretion of Zidovudine can be increased when combined with Methyltestosterone.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Metoclopramide.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be increased when combined with Zidovudine.]
[V04CD01, metyrapone, The metabolism of Zidovudine can be decreased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Zidovudine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of bleeding can be increased when Zidovudine is combined with Aminophenazone.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Zidovudine.]
[G03XB01, mifepristone, The serum concentration of Zidovudine can be increased when it is combined with Mifepristone.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Zidovudine.]
[C09CA03, valsartan, The metabolism of Zidovudine can be decreased when combined with Valsartan.]
[J01AA08, minocycline, The excretion of Zidovudine can be decreased when combined with Minocycline.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be increased when combined with Zidovudine.]
[L01XX23, mitotane, The metabolism of Zidovudine can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Mitoxantrone.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Zidovudine.]
[C01BD01, amiodarone, The metabolism of Zidovudine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Zidovudine can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Morphine can be increased when combined with Zidovudine.]
[L04AB05, certolizumab pegol, The metabolism of Zidovudine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Zidovudine.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Zidovudine.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be increased when combined with Zidovudine.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be increased when combined with Zidovudine.]
[P01BA06, amodiaquine, Zidovudine may increase the neutropenic activities of Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Raloxifene can be increased when combined with Zidovudine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Zidovudine.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Zidovudine.]
[J01CA04, amoxicillin, The excretion of Zidovudine can be decreased when combined with Amoxicillin.]
[J01CF06, nafcillin, The excretion of Zidovudine can be decreased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Zidovudine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be increased when combined with Zidovudine.]
[L04AC03, anakinra, The metabolism of Zidovudine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Zidovudine can be decreased when combined with Amphetamine.]
[M02AA12, naproxen, The risk or severity of bleeding can be increased when Zidovudine is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Troglitazone can be increased when combined with Zidovudine.]
[N06AX21, duloxetine, The metabolism of Zidovudine can be decreased when combined with Duloxetine.]
[L01CD02, docetaxel, The risk or severity of adverse effects can be increased when Zidovudine is combined with Docetaxel.]
[L02BG04, letrozole, The metabolism of Zidovudine can be decreased when combined with Letrozole.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Zidovudine.]
[B01AC17, tirofiban, The risk or severity of bleeding can be increased when Tirofiban is combined with Zidovudine.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Zidovudine can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of adverse effects can be increased when Valaciclovir is combined with Zidovudine.]
[M04AA03, febuxostat, The excretion of Zidovudine can be decreased when combined with Febuxostat.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Zidovudine.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Zidovudine can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Zidovudine.]
[N07BA01, nicotine, The metabolism of Zidovudine can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Zidovudine.]
[M02AA17, niflumic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Niflumic acid.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Zidovudine can be increased when combined with Bosentan.]
[R05DA07, noscapine, The metabolism of Zidovudine can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Zidovudine.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Zidovudine.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Zidovudine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Zidovudine.]
[C01AC01, ouabain, The excretion of Zidovudine can be decreased when combined with Ouabain.]
[A14AA08, oxandrolone, The metabolism of Zidovudine can be decreased when combined with Oxandrolone.]
[S01BC02, oxyphenbutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Zidovudine.]
[V04CH30, 4-aminohippuric acid, The excretion of Zidovudine can be decreased when combined with Aminohippuric acid.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Zidovudine.]
[H02AB05, paramethasone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Penicillamine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Zidovudine.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Zidovudine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Zidovudine.]
[N05CA01, pentobarbital, The metabolism of Zidovudine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Pentostatin.]
[C04AD03, pentoxifylline, The risk or severity of bleeding can be increased when Pentoxifylline is combined with Zidovudine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Zidovudine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Zidovudine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Zidovudine.]
[N03AA02, phenobarbital, The metabolism of Zidovudine can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Zidovudine.]
[M02AA01, phenylbutazone, The risk or severity of bleeding can be increased when Zidovudine is combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Zidovudine.]
[L04AB06, golimumab, The metabolism of Zidovudine can be increased when combined with Golimumab.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Zidovudine.]
[J05AB12, cidofovir, The excretion of Zidovudine can be decreased when combined with Cidofovir.]
[S01EB01, pilocarpine, The metabolism of Zidovudine can be decreased when combined with Pilocarpine.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be increased when combined with Zidovudine.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Zidovudine.]
[J05AE01, saquinavir, The metabolism of Zidovudine can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Eprosartan.]
[S01BC06, piroxicam, The risk or severity of bleeding can be increased when Zidovudine is combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Zidovudine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Zidovudine can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Zidovudine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Zidovudine.]
[A10BG02, rosiglitazone, The metabolism of Zidovudine can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Zidovudine.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Zidovudine.]
[L04AC08, canakinumab, The metabolism of Zidovudine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Zidovudine.]
[J05AE03, ritonavir, The serum concentration of Zidovudine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Zidovudine.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Pitavastatin.]
[S03BA02, prednisolone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Zidovudine is combined with Prednisone.]
[P01BA03, primaquine, The metabolism of Zidovudine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Zidovudine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Zidovudine can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Fenofibrate.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Zidovudine can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Zidovudine can be decreased when combined with Promethazine.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Zidovudine.]
[N01AX10, propofol, The metabolism of Propofol can be increased when combined with Zidovudine.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Zidovudine is combined with Propylthiouracil.]
[B01AC09, epoprostenol, The risk or severity of bleeding can be increased when Epoprostenol is combined with Zidovudine.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Zidovudine.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Zidovudine.]
[P01BD01, pyrimethamine, The metabolism of Zidovudine can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The excretion of Zidovudine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Zidovudine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Zidovudine.]
[J05AP01, ribavirin, The risk or severity of adverse effects can be increased when Zidovudine is combined with Ribavirin.]
[S01XA26, riboflavin, The excretion of Zidovudine can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The metabolism of Zidovudine can be increased when combined with Rifampicin.]
[N02BA05, salicylamide, The risk or severity of bleeding can be increased when Zidovudine is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of bleeding can be increased when Zidovudine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of bleeding can be increased when Zidovudine is combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Zidovudine can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Zidovudine.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Zidovudine is combined with Obinutuzumab.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Zidovudine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Zidovudine.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Zidovudine.]
[C03DA01, spironolactone, The metabolism of Zidovudine can be decreased when combined with Spironolactone.]
[N03AG01, valproic acid, The serum concentration of Zidovudine can be increased when it is combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The risk or severity of adverse effects can be increased when Zidovudine is combined with Hydrocortisone butyrate.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be increased when combined with Nevirapine.]
[J01EC02, sulfadiazine, The metabolism of Nevirapine can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Nevirapine can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Nevirapine can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Nevirapine can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Nevirapine can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Nevirapine can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Nevirapine can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Nevirapine.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Nevirapine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Nevirapine.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Nevirapine.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Nevirapine.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Nevirapine.]
[A04AD10, dronabinol, The metabolism of Nevirapine can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be increased when combined with Nevirapine.]
[L04AX02, thalidomide, The metabolism of Nevirapine can be increased when combined with Thalidomide.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Nevirapine.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Nevirapine.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be decreased when combined with Nevirapine.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Thiamine.]
[L01AC01, thiotepa, The metabolism of Nevirapine can be decreased when combined with Thiotepa.]
[N05AC02, thioridazine, The metabolism of Nevirapine can be decreased when combined with Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Nevirapine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Nevirapine.]
[B01AC05, ticlopidine, The metabolism of Nevirapine can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Nevirapine.]
[A10BB05, tolazamide, The metabolism of Tolazamide can be decreased when combined with Nevirapine.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Nevirapine.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Nevirapine.]
[N06AF04, tranylcypromine, The metabolism of Nevirapine can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The metabolism of Trazodone can be decreased when combined with Nevirapine.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be increased when combined with Nevirapine.]
[S01BA05, triamcinolone, The metabolism of Nevirapine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Triamterene can be decreased when combined with Nevirapine.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Nevirapine.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Nevirapine.]
[R03BA07, mometasone, The metabolism of Nevirapine can be increased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Nevirapine.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Nevirapine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Nevirapine.]
[R06AC04, tripelennamine, The metabolism of Nevirapine can be decreased when combined with Tripelennamine.]
[J01FA08, troleandomycin, The metabolism of Nevirapine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Nevirapine can be decreased when combined with Vilazodone.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Nevirapine.]
[L02BX03, abiraterone, The metabolism of Nevirapine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Nevirapine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Nevirapine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Nevirapine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Nevirapine can be decreased when combined with Rilpivirine.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Nevirapine.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Nevirapine.]
[C08DA01, verapamil, The metabolism of Verapamil can be increased when combined with Nevirapine.]
[N06AX09, viloxazine, The metabolism of Nevirapine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Nevirapine can be decreased when combined with Vinblastine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Nevirapine.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Nevirapine.]
[S01AA13, fusidic acid, The metabolism of Nevirapine can be decreased when combined with Fusidic acid.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Nevirapine.]
[J05AE02, indinavir, The serum concentration of Indinavir can be decreased when it is combined with Nevirapine.]
[L01EC01, vemurafenib, The metabolism of Nevirapine can be decreased when combined with Vemurafenib.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Nevirapine.]
[R03DC01, zafirlukast, The metabolism of Nevirapine can be decreased when combined with Zafirlukast.]
[N05AE04, ziprasidone, The metabolism of Nevirapine can be decreased when combined with Ziprasidone.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Nevirapine.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Nevirapine.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Nevirapine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Nevirapine.]
[J02AC03, voriconazole, The metabolism of Nevirapine can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Nevirapine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Nevirapine.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Nevirapine.]
[H02AB11, prednylidene, The metabolism of Nevirapine can be increased when combined with Prednylidene.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Nevirapine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Nevirapine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Nevirapine.]
[A08AA11, lorcaserin, The metabolism of Nevirapine can be decreased when combined with Lorcaserin.]
[G04BD12, mirabegron, The serum concentration of Nevirapine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The serum concentration of Cobicistat can be decreased when it is combined with Nevirapine.]
[J05AJ02, elvitegravir, The metabolism of Nevirapine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Nevirapine can be decreased when it is combined with Enzalutamide.]
[L01EX05, regorafenib, The metabolism of Nevirapine can be decreased when combined with Regorafenib.]
[J05AE04, nelfinavir, The metabolism of Nevirapine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Nevirapine.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be decreased when combined with Nevirapine.]
[C08CA13, lercanidipine, The metabolism of Lercanidipine can be decreased when combined with Nevirapine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Nevirapine.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Nevirapine.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Nevirapine.]
[G04BD10, darifenacin, The metabolism of Nevirapine can be decreased when combined with Darifenacin.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Nevirapine.]
[G04BE03, sildenafil, The metabolism of Nevirapine can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Nevirapine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Nevirapine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Nevirapine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Nevirapine can be decreased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Nevirapine.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be increased when combined with Nevirapine.]
[M04AB03, benzbromarone, The metabolism of Nevirapine can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Nevirapine can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be increased when combined with Nevirapine.]
[M01AH01, celecoxib, The metabolism of Nevirapine can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Nevirapine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Nevirapine.]
[L01EC02, dabrafenib, The serum concentration of Nevirapine can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Nevirapine.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Nevirapine.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be decreased when it is combined with Nevirapine.]
[C08EA02, bepridil, The metabolism of Nevirapine can be decreased when combined with Bepridil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Nevirapine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Nevirapine.]
[J05AP05, simeprevir, The metabolism of Nevirapine can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Nevirapine.]
[C07AB04, acebutolol, The metabolism of Nevirapine can be decreased when combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Nevirapine.]
[A16AA07, metreleptin, The metabolism of Nevirapine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Nevirapine can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Nevirapine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Nevirapine.]
[V03AB34, fomepizole, The metabolism of Nevirapine can be decreased when combined with Fomepizole.]
[L04AC11, siltuximab, The metabolism of Nevirapine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Nevirapine can be decreased when combined with Ceritinib.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Nevirapine.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Nevirapine.]
[A16AX10, eliglustat, The metabolism of Nevirapine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Nevirapine can be decreased when combined with Oritavancin.]
[N04AA02, biperiden, The metabolism of Nevirapine can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Nevirapine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Nevirapine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Nevirapine.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Nevirapine.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Nevirapine.]
[L04AC10, secukinumab, The metabolism of Nevirapine can be increased when combined with Secukinumab.]
[L01XH03, panobinostat, The metabolism of Nevirapine can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Nevirapine.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Nevirapine.]
[J05AP06, asunaprevir, The metabolism of Nevirapine can be decreased when combined with Asunaprevir.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Nevirapine.]
[A04AD14, rolapitant, The metabolism of Nevirapine can be decreased when combined with Rolapitant.]
[A02BC03, lansoprazole, The metabolism of Nevirapine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Nevirapine.]
[J02AC05, isavuconazole, The metabolism of Nevirapine can be decreased when combined with Isavuconazole.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Nevirapine.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Nevirapine.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Nevirapine.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be increased when combined with Nevirapine.]
[L01XX52, venetoclax, The metabolism of Nevirapine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Nevirapine.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be increased when combined with Nevirapine.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Nevirapine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Nevirapine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Nevirapine.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Nevirapine.]
[P01BE02, artemether, The metabolism of Artemether can be increased when combined with Nevirapine.]
[P01BE03, artesunate, The serum concentration of the active metabolites of Artesunate can be reduced when Artesunate is used in combination with Nevirapine resulting in a loss in efficacy.]
[S01GX07, azelastine, The metabolism of Nevirapine can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Nevirapine can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Nevirapine can be decreased when combined with Ribociclib.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Nevirapine.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Nevirapine.]
[N06BC01, caffeine, The metabolism of Caffeine can be decreased when combined with Nevirapine.]
[J05AE09, tipranavir, The metabolism of Nevirapine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Nevirapine.]
[L04AB02, infliximab, The metabolism of Nevirapine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Nevirapine can be decreased when combined with Midostaurin.]
[J01MA23, delafloxacin, The metabolism of Nevirapine can be increased when combined with Delafloxacin.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Nevirapine can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Nevirapine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Nevirapine.]
[J05AG03, efavirenz, The metabolism of Nevirapine can be decreased when combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Nevirapine.]
[R03BA02, budesonide, The metabolism of Nevirapine can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Nevirapine can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Nevirapine can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The metabolism of Capsaicin can be decreased when combined with Nevirapine.]
[L02BB05, apalutamide, The metabolism of Nevirapine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Nevirapine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Nevirapine.]
[N03AX24, cannabidiol, The metabolism of Nevirapine can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Nevirapine can be increased when combined with Avatrombopag.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Nevirapine.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Nevirapine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Nevirapine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Nevirapine.]
[L01XX62, ivosidenib, The metabolism of Nevirapine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Nevirapine.]
[N03AX17, stiripentol, The metabolism of Nevirapine can be decreased when combined with Stiripentol.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Nevirapine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Nevirapine.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Nevirapine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Nevirapine.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Nevirapine.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Nevirapine.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Nevirapine.]
[L04AA39, emapalumab, The metabolism of Nevirapine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Carmustine can be decreased when combined with Nevirapine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Nevirapine.]
[P02BX04, triclabendazole, The metabolism of Nevirapine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be increased when combined with Nevirapine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Nevirapine.]
[J01FA09, clarithromycin, The metabolism of Nevirapine can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Nevirapine.]
[N05BA09, clobazam, The metabolism of Nevirapine can be decreased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Nevirapine can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Nevirapine can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Nevirapine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Nevirapine can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Nevirapine can be decreased when it is combined with Alpelisib.]
[L01EX15, pexidartinib, Nevirapine may increase the hepatotoxic activities of Pexidartinib.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Nevirapine.]
[L01EJ02, fedratinib, The metabolism of Nevirapine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Nevirapine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Nevirapine.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Nevirapine.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Nevirapine.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Nevirapine.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Nevirapine.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be increased when combined with Nevirapine.]
[N03AX25, cenobamate, The serum concentration of Nevirapine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Nevirapine can be increased when it is combined with Givosiran.]
[R06AB02, dexchlorpheniramine, The metabolism of Nevirapine can be decreased when combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The metabolism of Nevirapine can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Nevirapine can be decreased when it is combined with Lemborexant.]
[M01AX21, diacetylrhein, The metabolism of Nevirapine can be decreased when combined with Diacerein.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be decreased when it is combined with Nevirapine.]
[J05AE05, amprenavir, The metabolism of Nevirapine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Nevirapine.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Nevirapine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Nevirapine.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Nevirapine.]
[N02CC06, eletriptan, The metabolism of Nevirapine can be increased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be decreased when combined with Nevirapine.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Nevirapine.]
[C08CA16, clevidipine, The metabolism of Nevirapine can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Nevirapine can be decreased when combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Nevirapine can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Nevirapine.]
[D07XB03, fluprednidene, The metabolism of Nevirapine can be increased when combined with Fluprednidene.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be increased when combined with Nevirapine.]
[G04BD09, trospium, The metabolism of Nevirapine can be decreased when combined with Trospium.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be increased when combined with Nevirapine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Nevirapine.]
[P01BB01, proguanil, The metabolism of Nevirapine can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Nevirapine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The metabolism of Oliceridine can be decreased when combined with Nevirapine.]
[P01BA01, chloroquine, The metabolism of Nevirapine can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Nevirapine can be decreased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The metabolism of Nevirapine can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Nevirapine can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Chlorpropamide can be decreased when combined with Nevirapine.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Nevirapine.]
[A11CC05, cholecalciferol, The metabolism of Nevirapine can be decreased when combined with Cholecalciferol.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Nevirapine is combined with Choline salicylate.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Nevirapine.]
[B06AC06, berotralstat, The metabolism of Nevirapine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Nevirapine can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The metabolism of Relugolix can be decreased when combined with Nevirapine.]
[P03AX07, abametapir, The serum concentration of Nevirapine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Nevirapine can be decreased when combined with Tepotinib.]
[N03AX10, felbamate, The metabolism of Nevirapine can be decreased when combined with Felbamate.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Nevirapine.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Nevirapine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Nevirapine.]
[L04AA50, ponesimod, The metabolism of Ponesimod can be decreased when combined with Nevirapine.]
[L03AB10, peginterferon alfa-2b, The metabolism of Nevirapine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Nevirapine can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Nevirapine.]
[L01XX73, sotorasib, The serum concentration of Nevirapine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Nevirapine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The metabolism of Nevirapine can be decreased when combined with Cisplatin.]
[N06AB04, citalopram, The metabolism of Nevirapine can be decreased when combined with Citalopram.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be increased when combined with Nevirapine.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Nevirapine.]
[R06AA04, clemastine, The metabolism of Nevirapine can be decreased when combined with Clemastine.]
[A10BB12, glimepiride, The metabolism of Nevirapine can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Nevirapine.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Nevirapine.]
[N06AX25, St. John's wort extract, The metabolism of Nevirapine can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Nevirapine can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Nevirapine can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Nevirapine.]
[J04BA01, clofazimine, The metabolism of Nevirapine can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Nevirapine can be decreased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Nevirapine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Nevirapine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Nevirapine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Nevirapine.]
[C01EB24, mavacamten, The serum concentration of Nevirapine can be decreased when it is combined with Mavacamten.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Nevirapine.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be increased when combined with Nevirapine.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Nevirapine.]
[N05AH02, clozapine, The metabolism of Nevirapine can be decreased when combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Nevirapine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The metabolism of Nevirapine can be decreased when combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Nevirapine can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Codeine.]
[L04AA13, leflunomide, The metabolism of Nevirapine can be decreased when combined with Leflunomide.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Nevirapine.]
[J01FA15, telithromycin, The metabolism of Nevirapine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Nevirapine.]
[M01AH03, valdecoxib, The metabolism of Nevirapine can be decreased when combined with Valdecoxib.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Nevirapine.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Nevirapine.]
[J02AC02, itraconazole, The serum concentration of Itraconazole can be decreased when it is combined with Nevirapine.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Nevirapine is combined with Acyclovir.]
[L01EA01, imatinib, The serum concentration of Nevirapine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Nevirapine can be decreased when combined with Posaconazole.]
[S01BA03, cortisone, The metabolism of Nevirapine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Nevirapine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Nevirapine.]
[C08CA11, manidipine, The metabolism of Nevirapine can be decreased when combined with Manidipine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Nevirapine.]
[H02AB15, meprednisone, The metabolism of Nevirapine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Nevirapine.]
[R06AE03, cyclizine, The metabolism of Nevirapine can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Nevirapine.]
[N05AD03, metylperon, The metabolism of Nevirapine can be decreased when combined with Melperone.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Nevirapine.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Nevirapine.]
[S01XA18, cyclosporine, The metabolism of Nevirapine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Nevirapine can be decreased when combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Nevirapine can be increased when combined with Armodafinil.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Nevirapine.]
[C03XA02, conivaptan, The metabolism of Nevirapine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Nevirapine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Nevirapine.]
[M01AH05, etoricoxib, The metabolism of Nevirapine can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Nevirapine.]
[G03XA01, danazol, The metabolism of Nevirapine can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Nevirapine.]
[L01DB02, daunorubicin, The metabolism of Nevirapine can be increased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Nevirapine.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Nevirapine.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Nevirapine.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Nevirapine.]
[N06AX06, nefazodone, The metabolism of Nevirapine can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Nevirapine can be decreased when combined with Nilutamide.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Nevirapine.]
[N06AB10, escitalopram, The serum concentration of Nevirapine can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Nevirapine.]
[N06AA01, desipramine, The metabolism of Nevirapine can be decreased when combined with Desipramine.]
[N03AF02, oxcarbazepine, The metabolism of Nevirapine can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Nevirapine can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Nevirapine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Nevirapine.]
[L04AB04, adalimumab, The metabolism of Nevirapine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Nevirapine.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Nevirapine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Nevirapine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Nevirapine.]
[N06AB05, paroxetine, The metabolism of Nevirapine can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Nevirapine.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Nevirapine.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Nevirapine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be increased when combined with Nevirapine.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Nevirapine.]
[L02AA01, diethylstilbestrol, The metabolism of Nevirapine can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Nevirapine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Nevirapine can be increased when combined with Difluocortolone.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Nevirapine.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Nevirapine.]
[J05AE08, atazanavir, The metabolism of Nevirapine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Nevirapine.]
[C08DB01, diltiazem, The metabolism of Nevirapine can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Nevirapine can be decreased when combined with Dimethyl sulfoxide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Nevirapine.]
[C05CA03, diosmin, The metabolism of Nevirapine can be decreased when combined with Diosmin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Nevirapine.]
[R06AA02, diphenhydramine, The metabolism of Nevirapine can be decreased when combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Nevirapine can be decreased when combined with Quazepam.]
[A03FA02, cisapride, The metabolism of Nevirapine can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Nevirapine.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Nevirapine.]
[C01BA03, disopyramide, The metabolism of Disopyramide can be decreased when combined with Nevirapine.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Nevirapine.]
[S02AA12, rifamycin SV, The metabolism of Nevirapine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Nevirapine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Nevirapine.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Nevirapine.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be decreased when combined with Nevirapine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Nevirapine.]
[A04AD12, aprepitant, The metabolism of Nevirapine can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Nevirapine.]
[G04BE08, tadalafil, The metabolism of Tadalafil can be decreased when combined with Nevirapine.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Nevirapine.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Nevirapine.]
[C01EB18, ranolazine, The serum concentration of Nevirapine can be increased when it is combined with Ranolazine.]
[R03AC12, salmeterol, The risk or severity of adverse effects can be increased when Nevirapine is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Nevirapine.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Nevirapine can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Nevirapine.]
[L01DB01, doxorubicin, The metabolism of Nevirapine can be decreased when combined with Doxorubicin.]
[N06AB06, sertraline, The metabolism of Nevirapine can be decreased when combined with Sertraline.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be increased when combined with Nevirapine.]
[C10AA01, simvastatin, The metabolism of Nevirapine can be increased when combined with Simvastatin.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Nevirapine.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be decreased when combined with Nevirapine.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Nevirapine.]
[D01BA02, terbinafine, The metabolism of Nevirapine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Nevirapine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Nevirapine.]
[C03CA04, torsemide, The metabolism of Nevirapine can be decreased when combined with Torasemide.]
[L01CA04, vinorelbine, The metabolism of Nevirapine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The metabolism of Epinastine can be increased when combined with Nevirapine.]
[N06AX16, venlafaxine, The metabolism of Nevirapine can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Nevirapine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Nevirapine can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Nevirapine.]
[N03AX15, zonisamide, The metabolism of Zonisamide can be decreased when combined with Nevirapine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Nevirapine.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Nevirapine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Guanfacine.]
[N02CA02, ergotamine, The metabolism of Nevirapine can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be increased when combined with Nevirapine.]
[S01AA17, erythromycin, The metabolism of Nevirapine can be decreased when combined with Erythromycin.]
[H05BX01, cinacalcet, The metabolism of Nevirapine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Nevirapine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Nevirapine.]
[J04AK02, ethambutol, The metabolism of Nevirapine can be decreased when combined with Ethambutol.]
[R03BA05, fluticasone, The metabolism of Nevirapine can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Nevirapine can be increased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Nevirapine.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Nevirapine.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be increased when combined with Nevirapine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Nevirapine.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Nevirapine.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Nevirapine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Nevirapine.]
[R06AX12, terfenadine, The metabolism of Nevirapine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Nevirapine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Nevirapine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Nevirapine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Nevirapine.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Nevirapine.]
[C08CA02, felodipine, The metabolism of Nevirapine can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be decreased when it is combined with Nevirapine.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Nevirapine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Nevirapine.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Nevirapine.]
[J02AC01, fluconazole, The serum concentration of Nevirapine can be increased when it is combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Nevirapine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be increased when combined with Nevirapine.]
[D07AC08, fluocinonide, The metabolism of Nevirapine can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Nevirapine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Nevirapine can be decreased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Nevirapine can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Nevirapine.]
[N06AB03, fluoxetine, The serum concentration of Nevirapine can be increased when it is combined with Fluoxetine.]
[N05AB02, fluphenazine, The metabolism of Nevirapine can be decreased when combined with Fluphenazine.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Nevirapine.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Nevirapine.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Nevirapine.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Nevirapine.]
[J05AE10, darunavir, The serum concentration of Nevirapine can be increased when it is combined with Darunavir.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Nevirapine.]
[S01AD09, ganciclovir, The risk or severity of adverse effects can be increased when Nevirapine is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The metabolism of Nevirapine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Nevirapine.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Nevirapine.]
[J05AG04, etravirine, The metabolism of Nevirapine can be decreased when combined with Etravirine.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Nevirapine.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Nevirapine.]
[A10BB01, glyburide, The metabolism of Nevirapine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Nevirapine.]
[A10BB07, glipizide, The metabolism of Glipizide can be decreased when combined with Nevirapine.]
[N05CM18, dexmedetomidine, The metabolism of Nevirapine can be decreased when combined with Dexmedetomidine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Nevirapine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Nevirapine.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Nevirapine.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Nevirapine.]
[P01BX01, halofantrine, The metabolism of Nevirapine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Nevirapine.]
[N01AB01, halothane, The metabolism of Halothane can be increased when combined with Nevirapine.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Nevirapine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Nevirapine.]
[C09CA01, losartan, The metabolism of Losartan can be decreased when combined with Nevirapine.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Nevirapine.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Nevirapine.]
[R03BA09, fluticasone furoate, The metabolism of Nevirapine can be decreased when combined with Fluticasone furoate.]
[C08CA10, nilvadipine, The metabolism of Nevirapine can be decreased when combined with Nilvadipine.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be increased when combined with Nevirapine.]
[S02BA01, hydrocortisone, The metabolism of Nevirapine can be increased when combined with Hydrocortisone.]
[P01BA02, hydroxychloroquine, The metabolism of Nevirapine can be decreased when combined with Hydroxychloroquine.]
[N05BB01, hydroxyzine, The metabolism of Nevirapine can be decreased when combined with Hydroxyzine.]
[J04AB04, rifabutin, The serum concentration of Rifabutin can be decreased when it is combined with Nevirapine.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Nevirapine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Nevirapine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Nevirapine.]
[N06AA02, imipramine, The metabolism of Nevirapine can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Nevirapine.]
[M03BX02, tizanidine, The serum concentration of Tizanidine can be increased when it is combined with Nevirapine.]
[S01BC01, indomethacin, The metabolism of Indomethacin can be decreased when combined with Nevirapine.]
[N06AX17, milnacipran, The metabolism of Nevirapine can be decreased when combined with Milnacipran.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Nevirapine.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Nevirapine.]
[C10AA06, cerivastatin, The metabolism of Nevirapine can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be decreased when combined with Nevirapine.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Nevirapine.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Nevirapine.]
[N06AF05, iproniazid, The metabolism of Nevirapine can be decreased when combined with Iproniazid.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be decreased when combined with Nevirapine.]
[P01AX06, atovaquone, The metabolism of Nevirapine can be decreased when combined with Atovaquone.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be increased when combined with Nevirapine.]
[N04BX02, entacapone, The metabolism of Nevirapine can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Nevirapine can be decreased when combined with Isoniazid.]
[N06AX18, reboxetine, The metabolism of Nevirapine can be decreased when combined with Reboxetine.]
[L04AC07, tocilizumab, The metabolism of Nevirapine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be increased when combined with Nevirapine.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be increased when combined with Nevirapine.]
[J02AB02, ketoconazole, The metabolism of Nevirapine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Nevirapine.]
[L04AA24, abatacept, The metabolism of Nevirapine can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The metabolism of Nevirapine can be decreased when combined with Rotigotine.]
[C07AG01, labetalol, The metabolism of Nevirapine can be decreased when combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Amantadine.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Nevirapine.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Nevirapine.]
[S02DA01, lidocaine, The metabolism of Nevirapine can be decreased when combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Nevirapine can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Nevirapine.]
[C10AA02, lovastatin, The metabolism of Nevirapine can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Nevirapine.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Nevirapine.]
[L01EA03, nilotinib, The metabolism of Nevirapine can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Nevirapine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Nevirapine.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Nevirapine.]
[N06DX01, memantine, The metabolism of Nevirapine can be decreased when combined with Memantine.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Nevirapine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be increased when combined with Nevirapine.]
[N03AA01, mephobarbital, The metabolism of Methylphenobarbital can be increased when combined with Nevirapine.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Nevirapine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Nevirapine.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Nevirapine.]
[N07BC02, methadone, The metabolism of Methadone can be increased when combined with Nevirapine.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Nevirapine.]
[H03BB02, methimazole, The metabolism of Nevirapine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Nevirapine.]
[N05AA02, methotrimeprazine, The metabolism of Nevirapine can be decreased when combined with Methotrimeprazine.]
[D05BA02, methoxsalen, The metabolism of Nevirapine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be increased when combined with Nevirapine.]
[V04CG05, methylene blue, The metabolism of Nevirapine can be decreased when combined with Methylene blue.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Nevirapine.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be increased when combined with Nevirapine.]
[A03FA01, metoclopramide, The metabolism of Nevirapine can be decreased when combined with Metoclopramide.]
[C07AB02, metoprolol, The metabolism of Nevirapine can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Nevirapine.]
[V04CD01, metyrapone, The metabolism of Nevirapine can be decreased when combined with Metyrapone.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be increased when combined with Nevirapine.]
[N06AX03, mianserin, The metabolism of Mianserin can be increased when combined with Nevirapine.]
[S02AA13, miconazole, The metabolism of Nevirapine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Nevirapine.]
[N05CD08, midazolam, The metabolism of Midazolam can be decreased when combined with Nevirapine.]
[G03XB01, mifepristone, The metabolism of Nevirapine can be decreased when combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Nevirapine can be decreased when combined with Valsartan.]
[L01XX23, mitotane, The metabolism of Nevirapine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Nevirapine.]
[C01BD01, amiodarone, The metabolism of Nevirapine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Nevirapine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Nevirapine.]
[L04AB05, certolizumab pegol, The metabolism of Nevirapine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Nevirapine.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Nevirapine.]
[P01BA06, amodiaquine, The metabolism of Nevirapine can be decreased when combined with Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Nevirapine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Nevirapine.]
[N03AB05, fosphenytoin, The metabolism of Nevirapine can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Nevirapine.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be decreased when combined with Nevirapine.]
[V03AB15, naloxone, The metabolism of Nevirapine can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Nevirapine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Nevirapine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Nevirapine.]
[A10BG01, troglitazone, The metabolism of Nevirapine can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Nevirapine can be decreased when combined with Duloxetine.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Nevirapine.]
[L02BG04, letrozole, The metabolism of Nevirapine can be decreased when combined with Letrozole.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Nevirapine.]
[N06AX23, desvenlafaxine, The metabolism of Nevirapine can be decreased when combined with Desvenlafaxine.]
[C10AD02, niacin, The metabolism of Nevirapine can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Nevirapine can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Nevirapine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Nevirapine.]
[N07BA01, nicotine, The metabolism of Nicotine can be increased when combined with Nevirapine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Nevirapine.]
[C08CA07, nisoldipine, The metabolism of Nisoldipine can be decreased when combined with Nevirapine.]
[C08CA08, nitrendipine, The metabolism of Nitrendipine can be decreased when combined with Nevirapine.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Nevirapine.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Nevirapine is combined with Pramipexole.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Norepinephrine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Nevirapine.]
[C02KX01, bosentan, The metabolism of Nevirapine can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Nevirapine.]
[R05DA07, noscapine, The metabolism of Nevirapine can be decreased when combined with Noscapine.]
[L04AC04, rilonacept, The metabolism of Nevirapine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Nevirapine can be decreased when combined with Omeprazole.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Nevirapine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Nevirapine.]
[P02BA02, oxamniquine, The metabolism of Nevirapine can be decreased when combined with Oxamniquine.]
[A14AA08, oxandrolone, The metabolism of Nevirapine can be decreased when combined with Oxandrolone.]
[C07AA02, oxprenolol, The metabolism of Nevirapine can be decreased when combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Nevirapine.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Nevirapine.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Nevirapine.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Nevirapine is combined with Pancuronium.]
[H02AB05, paramethasone, The metabolism of Nevirapine can be increased when combined with Paramethasone.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Nevirapine.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Nevirapine.]
[N05CA01, pentobarbital, The metabolism of Nevirapine can be increased when combined with Pentobarbital.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be decreased when combined with Nevirapine.]
[C08EX02, perhexiline, The metabolism of Nevirapine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The metabolism of Nevirapine can be decreased when combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Nevirapine.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Nevirapine is combined with Phenformin.]
[N03AA02, phenobarbital, The metabolism of Nevirapine can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Nevirapine.]
[M02AA01, phenylbutazone, The metabolism of Nevirapine can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Nevirapine can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Nevirapine can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Nevirapine can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Nevirapine can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Nevirapine.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Nevirapine.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Nevirapine.]
[J05AE01, saquinavir, The serum concentration of Saquinavir can be decreased when it is combined with Nevirapine.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Nevirapine.]
[N05AC04, pipothiazine, The metabolism of Nevirapine can be decreased when combined with Pipotiazine.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Nevirapine.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be decreased when combined with Nevirapine.]
[J05AG02, delavirdine, The metabolism of Nevirapine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Irbesartan can be decreased when combined with Nevirapine.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Nevirapine.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Nevirapine.]
[L04AC08, canakinumab, The metabolism of Nevirapine can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Nevirapine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Nevirapine.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Nevirapine.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Nevirapine.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Nevirapine.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Nevirapine is combined with Prazosin.]
[H02AB07, prednisone, The metabolism of Nevirapine can be increased when combined with Prednisone.]
[P01BA03, primaquine, The metabolism of Nevirapine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Nevirapine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Nevirapine can be decreased when combined with Probenecid.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Nevirapine.]
[C10AB05, fenofibrate, The metabolism of Nevirapine can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Nevirapine.]
[G03DA04, progesterone, The metabolism of Nevirapine can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Nevirapine.]
[R06AD02, promethazine, The metabolism of Promethazine can be increased when combined with Nevirapine.]
[C01BC03, propafenone, The metabolism of Nevirapine can be decreased when combined with Propafenone.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Nevirapine.]
[N01AX10, propofol, The metabolism of Propofol can be increased when combined with Nevirapine.]
[N02AC04, propoxyphene, The metabolism of Nevirapine can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Nevirapine.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Nevirapine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Nevirapine.]
[R06AC01, pyrilamine, The metabolism of Nevirapine can be decreased when combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Nevirapine.]
[C01BA01, quinidine, The metabolism of Quinidine can be decreased when combined with Nevirapine.]
[P01BC01, quinine, The metabolism of Nevirapine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Nevirapine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The metabolism of Nevirapine can be increased when combined with Reserpine.]
[J04AB02, rifampin, The metabolism of Nevirapine can be increased when combined with Rifampicin.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Nevirapine.]
[N04BD01, selegiline, The metabolism of Selegiline can be increased when combined with Nevirapine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Nevirapine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Nevirapine.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Nevirapine.]
[H02CA04, levoketoconazole, The metabolism of Nevirapine can be decreased when combined with Levoketoconazole.]
[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01GA01, streptomycin, Lamivudine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01CG01, sulbactam, Lamivudine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Sulfamethoxazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Lamivudine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R03CC03, terbutaline, Lamivudine may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Lamivudine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S03AA02, tetracycline, Lamivudine may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Lamivudine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[A11DA01, thiamine, The serum concentration of Lamivudine can be increased when it is combined with Thiamine.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BE06, moxisylyte, Lamivudine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Lamivudine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01AB02, tinidazole, Lamivudine may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Lamivudine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Lamivudine may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Lamivudine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Lamivudine.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Triazolam.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Lamivudine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A03AA05, trimebutine, Lamivudine may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, The serum concentration of Lamivudine can be increased when it is combined with Trimethoprim.]
[R03DX07, roflumilast, Lamivudine may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Lamivudine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, Vandetanib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R02AA14, oxyquinoline, Lamivudine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Lamivudine can be increased when it is combined with Linagliptin.]
[S01AA28, vancomycin, Lamivudine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Lamivudine may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Lamivudine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The risk or severity of adverse effects can be increased when Verapamil is combined with Lamivudine.]
[N06AX09, viloxazine, Lamivudine may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Lamivudine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B01AA03, warfarin, Lamivudine may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Lamivudine.]
[L01EC01, vemurafenib, Vemurafenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Lamivudine.]
[M05BA05, tiludronic acid, Lamivudine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Lamivudine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The serum concentration of Lamivudine can be increased when it is combined with Crizotinib.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ibandronate.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Lamivudine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Lamivudine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Lamivudine may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Lamivudine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[M01CB03, auranofin, Lamivudine may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, Vismodegib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B03XA04, peginesatide, Lamivudine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Lamivudine may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Lamivudine may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BE10, avanafil, Avanafil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Lamivudine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Lamivudine.]
[A08AA11, lorcaserin, Lamivudine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Lamivudine may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, Cobicistat may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L02BB04, enzalutamide, Lamivudine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[L04AA31, teriflunomide, Teriflunomide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EX05, regorafenib, Regorafenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[D02BA02, octinoxate, Lamivudine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, Nelfinavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N04BD02, rasagiline, Lamivudine may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Lamivudine.]
[V09IX04, fluorodeoxyglucose F18, Lamivudine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Lamivudine.]
[V08CA11, gadofosveset, Lamivudine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, Ponatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A16AX08, teduglutide, Lamivudine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Lamivudine may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Lamivudine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Lamivudine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[J02AX04, caspofungin, The excretion of Lamivudine can be decreased when combined with Caspofungin.]
[L03AA12, ancestim, Lamivudine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EC02, dabrafenib, Dabrafenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EE01, trametinib, Lamivudine may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Lamivudine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, Afatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06AX28, levomilnacipran, Lamivudine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[A10BJ03, lixisenatide, Lamivudine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Lamivudine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Lamivudine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AP08, sofosbuvir, Lamivudine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Lamivudine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Lamivudine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Lamivudine may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Lamivudine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Lamivudine.]
[V03AB34, fomepizole, Lamivudine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Bezafibrate.]
[N07XX08, tafamidis, The serum concentration of Lamivudine can be increased when it is combined with Tafamidis.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S03AA06, gentamicin, Lamivudine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, Dasabuvir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B01AF03, edoxaban, Lamivudine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EF01, palbociclib, Palbociclib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EX08, lenvatinib, The serum concentration of Lamivudine can be increased when it is combined with Lenvatinib.]
[J05AP07, daclatasvir, Daclatasvir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A04AD14, rolapitant, Rolapitant may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Acipimox.]
[A02BC03, lansoprazole, Lansoprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V03AB37, idarucizumab, Lamivudine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Trabectedin.]
[J02AC05, isavuconazole, Isavuconazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EB04, osimertinib, Osimertinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Lamivudine.]
[L01XG03, ixazomib, Lamivudine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[L01ED03, alectinib, Alectinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M04AB05, lesinurad, Lamivudine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, Elbasvir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AP11, grazoprevir, Grazoprevir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AX23, brivaracetam, Lamivudine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, Venetoclax may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05BA08, bromazepam, Lamivudine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Lamivudine may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Lamivudine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[N07BC01, buprenorphine, Buprenorphine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Lamivudine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01XK03, rucaparib, Rucaparib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A06AH05, naldemedine, Lamivudine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Lamivudine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01CA02, benznidazole, Lamivudine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The excretion of Lamivudine can be decreased when combined with Linezolid.]
[N07XX13, valbenazine, Lamivudine may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Lamivudine.]
[L01ED04, brigatinib, Brigatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N04BD03, safinamide, Safinamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01MA23, delafloxacin, Lamivudine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[L01BC06, capecitabine, Lamivudine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, Enasidenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EF03, abemaciclib, Abemaciclib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Lamivudine may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Lamivudine may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Captopril.]
[L02BB05, apalutamide, The serum concentration of Lamivudine can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, Lamivudine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01CA03, carbenicillin, The excretion of Lamivudine can be decreased when combined with Carbenicillin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Lamivudine.]
[B02BX09, fostamatinib, Fostamatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AX24, cannabidiol, Cannabidiol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B02BX08, avatrombopag, Avatrombopag may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AA37, baricitinib, Lamivudine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01GB14, plazomicin, Lamivudine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[P01BA07, tafenoquine, The serum concentration of Lamivudine can be increased when it is combined with Tafenoquine.]
[A16AX14, migalastat, Lamivudine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The excretion of Lamivudine can be decreased when combined with Stiripentol.]
[L01EB07, dacomitinib, Dacomitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[D08AE05, chloroxylenol, Lamivudine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EX13, gilteritinib, Gilteritinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01XJ03, glasdegib, Glasdegib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A06AX05, prucalopride, Lamivudine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Lamivudine may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ciprofibrate.]
[N06BA14, solriamfetol, Lamivudine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The serum concentration of Lamivudine can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ubidecarenone.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Lamivudine can be increased when it is combined with Darolutamide.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EJ02, fedratinib, Fedratinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N07XX11, pitolisant, The risk or severity of adverse effects can be increased when Pitolisant is combined with Lamivudine.]
[N04CX01, istradefylline, Istradefylline may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Lamivudine.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02CC08, lasmiditan, The serum concentration of Lamivudine can be increased when it is combined with Lasmiditan.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M09AX08, golodirsen, Lamivudine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Lamivudine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Lamivudine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Lamivudine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C08CA16, clevidipine, Lamivudine may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[C01BD07, dronedarone, The serum concentration of Lamivudine can be increased when it is combined with Dronedarone.]
[S03AA08, chloramphenicol, The excretion of Lamivudine can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The serum concentration of Lamivudine can be increased when it is combined with Tucatinib.]
[L01EX17, capmatinib, The serum concentration of Lamivudine can be increased when it is combined with Capmatinib.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EX19, ripretinib, Ripretinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V08CA05, mangafodipir, Lamivudine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AX29, fostemsavir, Fostemsavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Lamivudine.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The serum concentration of Lamivudine can be increased when it is combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02BA03, choline salicylate, The serum concentration of Lamivudine can be increased when it is combined with Choline salicylate.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Etofibrate.]
[M01AX25, chondroitin sulfates, Lamivudine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Lamivudine can be decreased when combined with Cabotegravir.]
[L01EX21, tepotinib, Tepotinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V03AF12, trilaciclib, The serum concentration of Lamivudine can be increased when it is combined with Trilaciclib.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01CA19, fenoldopam, Lamivudine may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01JA01, fluorescein, The excretion of Lamivudine can be decreased when combined with Fluorescein.]
[N02BG07, flupirtine, Lamivudine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Formoterol is combined with Lamivudine.]
[L01EK03, tivozanib, Tivozanib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A02BA01, cimetidine, The serum concentration of Lamivudine can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01MB06, cinoxacin, The excretion of Lamivudine can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Lamivudine can be increased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Lamivudine.]
[L01XA01, cisplatin, Lamivudine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AA48, belumosudil, Belumosudil may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01CA03, fexinidazole, The serum concentration of Lamivudine can be increased when it is combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Lamivudine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Lamivudine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Lamivudine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AX10, maribavir, Maribavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J04BA01, clofazimine, Clofazimine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Lamivudine.]
[N01BB10, levobupivacaine, Lamivudine may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Lamivudine can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Lamivudine may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Lamivudine may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J02AC06, oteseconazole, The serum concentration of Lamivudine can be increased when it is combined with Oteseconazole.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BK06, sotagliflozin, Sotagliflozin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01GB12, arbekacin, Lamivudine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Lamivudine.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Colchicine.]
[J01XB01, colistin, Lamivudine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Leflunomide.]
[A04AA03, tropisetron, Lamivudine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Lamivudine may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AB14, valganciclovir, The risk or severity of cytopenia can be increased when Valganciclovir is combined with Lamivudine.]
[C05BB03, invert sugar, Lamivudine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Lamivudine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Lamivudine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Lamivudine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Lamivudine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02CC05, almotriptan, Lamivudine may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J02AC02, itraconazole, Itraconazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01AD03, acyclovir, The risk or severity of adverse effects can be increased when Acyclovir is combined with Lamivudine.]
[N05BA10, ketazolam, Lamivudine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AX09, lamotrigine, The serum concentration of Lamivudine can be increased when it is combined with Lamotrigine.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Lamivudine.]
[N07BC04, lofexidine, Lamivudine may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C09AA03, lisinopril, Lamivudine may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Lamivudine may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Mebeverine.]
[J01DH02, meropenem, Lamivudine may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Lamivudine may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01XA18, cyclosporine, Cyclosporine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Cytarabine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01AX04, dacarbazine, Lamivudine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N07BB05, nalmefene, Lamivudine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Lamivudine may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Lamivudine may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Lamivudine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06AA01, desipramine, The serum concentration of Lamivudine can be increased when it is combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V04CH02, indigo carmine, Lamivudine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S03BA01, dexamethasone, Dexamethasone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EB01, gefitinib, Gefitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B01AC04, clopidogrel, The serum concentration of Lamivudine can be increased when it is combined with Clopidogrel.]
[P03AC04, permethrin, Lamivudine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Lamivudine may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R05DA08, pholcodine, Lamivudine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A03AA07, dicyclomine, Lamivudine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Lamivudine may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01EB02, erlotinib, Erlotinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[D07XC04, diflucortolone, Lamivudine may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01AA05, digoxin, Lamivudine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Lamivudine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Lamivudine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[V03AB09, dimercaprol, Lamivudine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Lamivudine may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G02AD02, dinoprostone, The serum concentration of Lamivudine can be increased when it is combined with Dinoprostone.]
[R06AA02, diphenhydramine, The serum concentration of Lamivudine can be increased when it is combined with Diphenhydramine.]
[S01AX06, resorcinol, Lamivudine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The serum concentration of Lamivudine can be increased when it is combined with Disopyramide.]
[R06AE09, levocetirizine, Lamivudine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01EX01, sunitinib, Sunitinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Lamivudine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01EB18, ranolazine, The serum concentration of Lamivudine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R03AC12, salmeterol, The serum concentration of Lamivudine can be increased when it is combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01CA07, dobutamine, Lamivudine may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, The serum concentration of Lamivudine can be increased when it is combined with Dopamine.]
[N06AA12, doxepin, Lamivudine may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A08AA10, sibutramine, Lamivudine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Lamivudine.]
[A12CA02, sodium sulfate, Lamivudine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V04CX07, edrophonium, Lamivudine may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[J01CG02, tazobactam, The excretion of Lamivudine can be decreased when combined with Tazobactam.]
[L01AX03, temozolomide, Lamivudine may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Lamivudine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06AG03, toloxatone, Lamivudine may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Lamivudine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N06AX16, venlafaxine, Venlafaxine may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01EA01, epinephrine, The serum concentration of Lamivudine can be increased when it is combined with Epinephrine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Lamivudine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Iloprost.]
[N03AG01, valproic acid, The excretion of Lamivudine can be decreased when combined with Valproic acid.]
[L03AX05, pidotimod, Lamivudine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Lamivudine may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Lamivudine.]
[P01AX07, trimetrexate, Lamivudine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The excretion of Lamivudine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Lamivudine.]
[C10AA03, pravastatin, Pravastatin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Lamivudine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Lamivudine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A02BA03, famotidine, The serum concentration of Lamivudine can be increased when it is combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02AB03, fentanyl, Lamivudine may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Lamivudine may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Lamivudine.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BD02, flavoxate, Lamivudine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J02AX01, flucytosine, Lamivudine may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Lamivudine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05CD01, flurazepam, The serum concentration of Lamivudine can be increased when it is combined with Flurazepam.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S02AA17, fosfomycin, Lamivudine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01BC03, tegafur, Lamivudine may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Lamivudine.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01AD09, ganciclovir, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Lamivudine.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Gemfibrozil.]
[J01XA03, telavancin, Lamivudine may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, Dasatinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BB01, glyburide, The excretion of Lamivudine can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Lamivudine may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Lamivudine.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01CB04, aurothioglucose, Lamivudine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Lamivudine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EX01, guanethidine, Lamivudine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05AH04, quetiapine, Lamivudine may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Lamivudine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C09CA01, losartan, The excretion of Lamivudine can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, Lamivudine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C09AA04, perindopril, Lamivudine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Lamivudine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Lamivudine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BD06, propiverine, Lamivudine may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Lamivudine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Risedronic acid.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[B05XA08, sodium acetate, Lamivudine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Lamivudine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, The serum concentration of Lamivudine can be increased when it is combined with Imipramine.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Paclitaxel.]
[R01AD07, tixocortol, Lamivudine may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Lamivudine may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A11HA07, inositol, Lamivudine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Lamivudine may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, The serum concentration of Lamivudine can be increased when it is combined with Varenicline.]
[A10BH01, sitagliptin, Lamivudine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05CH02, ramelteon, Lamivudine may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Lamivudine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ipecac.]
[G04BE01, alprostadil, The excretion of Lamivudine can be decreased when combined with Alprostadil.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Isoniazid.]
[J05AX05, inosine pranobex, Lamivudine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Lamivudine may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Lamivudine.]
[S01AA24, kanamycin, Lamivudine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine.]
[N01AX03, ketamine, Lamivudine may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Lamivudine may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[H02CA04, levoketoconazole, The serum concentration of Lamivudine can be increased when it is combined with Levoketoconazole.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N04BB01, amantadine, The serum concentration of Lamivudine can be increased when it is combined with Amantadine.]
[A06AX03, lubiprostone, Lamivudine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA21, amikacin, Lamivudine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, The serum concentration of Lamivudine can be increased when it is combined with Amiloride.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Lamivudine.]
[B05XA11, magnesium chloride, Lamivudine may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Lamivudine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Lamivudine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, Nilotinib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Lamivudine may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Lamivudine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Lamivudine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N01BB03, mepivacaine, Lamivudine may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Lamivudine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Lamivudine may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06BA03, methamphetamine, Lamivudine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Lamivudine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[J01MB02, nalidixic acid, The excretion of Lamivudine can be decreased when combined with Nalidixic acid.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Lamivudine may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Lamivudine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methotrexate is combined with Lamivudine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Methyldopa.]
[V04CG05, methylene blue, The serum concentration of Lamivudine can be increased when it is combined with Methylene blue.]
[G03EK01, methyltestosterone, Lamivudine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The serum concentration of Lamivudine can be increased when it is combined with Metoprolol.]
[V04CD01, metyrapone, Lamivudine may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Minocycline.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01BD01, amiodarone, The serum concentration of Lamivudine can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Lamivudine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[B02BX05, eltrombopag, Eltrombopag may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BA01, ammonium chloride, Lamivudine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Lamivudine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[C07AA12, nadolol, Lamivudine may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Lamivudine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The excretion of Lamivudine can be decreased when combined with Nafcillin.]
[V03AB15, naloxone, Lamivudine may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Lamivudine.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Letrozole.]
[S03AA01, neomycin, Lamivudine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Lamivudine may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Lamivudine.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L03AX16, plerixafor, Lamivudine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Lamivudine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Lamivudine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M04AA03, febuxostat, The excretion of Lamivudine can be decreased when combined with Febuxostat.]
[C01CE01, inamrinone, Lamivudine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Lamivudine.]
[N07BA01, nicotine, The serum concentration of Lamivudine can be increased when it is combined with Nicotine.]
[C08CA05, nifedipine, Lamivudine may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05CF03, zaleplon, Lamivudine may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C01CA03, norepinephrine, The serum concentration of Lamivudine can be increased when it is combined with Norepinephrine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Norfloxacin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Ofloxacin.]
[A02BC01, omeprazole, Omeprazole may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N02AA02, opium, Lamivudine may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01CF04, oxacillin, Lamivudine may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Lamivudine may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, The serum concentration of Lamivudine can be increased when it is combined with Oxprenolol.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01AA04, oxytetracycline, The excretion of Lamivudine can be decreased when combined with Oxytetracycline.]
[V04CH30, 4-aminohippuric acid, The serum concentration of Lamivudine can be increased when it is combined with Aminohippuric acid.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Pancuronium is combined with Lamivudine.]
[J04AB30, capreomycin, Lamivudine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[G04BD11, fesoterodine, Lamivudine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Lamivudine may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Lamivudine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[S01AA14, penicillin G, The excretion of Lamivudine can be decreased when combined with Benzylpenicillin.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[L01XX08, pentostatin, Lamivudine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Lamivudine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BE03, phenacetin, The excretion of Lamivudine can be decreased when combined with Phenacetin.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06AF03, phenelzine, Lamivudine may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[A10BA01, phenformin, The serum concentration of Lamivudine can be increased when it is combined with Phenformin.]
[C04AX02, phenoxybenzamine, The serum concentration of Lamivudine can be increased when it is combined with Phenoxybenzamine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Lamivudine.]
[S01AE05, levofloxacin, Lamivudine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Lamivudine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C07AA03, pindolol, Lamivudine may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J05AE01, saquinavir, Saquinavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N06BX03, piracetam, Lamivudine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Eprosartan.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The serum concentration of Lamivudine can be increased when it is combined with Grepafloxacin.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, Ritonavir may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A10BH03, saxagliptin, Lamivudine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Lamivudine may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Pitavastatin.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Lamivudine.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[M04AB01, probenecid, The serum concentration of Lamivudine can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Lamivudine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Fenofibrate.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[R06AD02, promethazine, Lamivudine may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Lamivudine may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Propofol.]
[C07AA05, propranolol, The serum concentration of Lamivudine can be increased when it is combined with Propranolol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Lamivudine.]
[N02CC04, rizatriptan, Lamivudine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Lamivudine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Lamivudine.]
[N07XX07, dalfampridine, Lamivudine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Lamivudine may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[P01AX05, quinacrine, The serum concentration of Lamivudine can be increased when it is combined with Quinacrine.]
[C01BA01, quinidine, Lamivudine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The serum concentration of Lamivudine can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The serum concentration of Lamivudine can be increased when it is combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Lamivudine.]
[J05AP01, ribavirin, Ribavirin may increase the hepatotoxic activities of Lamivudine.]
[S01XA26, riboflavin, The excretion of Lamivudine can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The excretion of Lamivudine can be decreased when combined with Rifampicin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[J01GB08, sisomicin, Lamivudine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Lamivudine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Lamivudine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, Cabazitaxel may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy.]
